Skip to content

The effects of orally and intraduodenally administered pea protein on satiety parameters in vivo in lean and obese subjects.

The effects of orally and intraduodenally administered pea protein on satiety parameters in vivo in lean and obese subjects. - The effects of pea protein on satiety parameters in vivo

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON34022
Enrollment
24
Registered
2008-12-15
Start date
2009-01-08
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesitas overweight

Interventions

During the first 4 testdays, subject will receive protein or placebo, either oral or intraduodenal administered. On the testdays with oral administration, samples will be taken from the intestinal f

Sponsors

Universiteit Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Male, non smoking • Age between 18 and 65 years • Body Mass Index between 20 and 37 kg/m2 • No medication that could interfere with the test results (e.g. glucose lowering medication) • No history of intestinal illness • Stable body weight over the last three months

Exclusion criteria

Exclusion criteria: • Age under 18 and over 65 years • BMI under 20 and over 37 kg/m2 • Medication or disease that could interfere with the results of the study, to be judged by the responsible medical doctor • Recent blood donation • Intestinal illness at any time in the past

Design outcomes

Primary

MeasureTime frame
We will be looking at the secreted satiety hormones by the biops. We will be looking at CCK, GLP-1, and PYY. We will also look at the hunger and satiety ratings of the subjects

Secondary

MeasureTime frame
-

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)